AVIA Launches Agentic AI Collaborative With 10 Health Systems
In 2023, the digital transformation company launched a similar collaborative around generative AI that involves 20 health systems
In 2023, the digital transformation company launched a similar collaborative around generative AI that involves 20 health systems
Cuando comience el período de inscripción abierta para adquirir cobertura médica en los mercados de seguros establecidos por la Ley de Cuidado de Salud a Bajo Precio, conocida como Obamacare, un grupo que antes no podía inscribirse será elegible por primera vez: los “Dreamers”. Ese es el nombre de los niños traídos a los Estados…
[Sponsored] In this webinar, sponsored by Solera Health, executives will share how companies can make the most of healthcare benefits. The post Exploring The Next Generation of Healthcare Benefits appeared first on MedCity News.
Trust in the U.S. healthcare system is eroding, but experts say rebuilding it is possible. They say this will require both payers and providers to prioritize empathy, transparency and personalized communication. The post Americans’ Trust in the Healthcare System Is Plummeting. How Can It Be Repaired? appeared first on MedCity News.
This brief reviews current state and federal policies, ongoing litigation, and potential federal actions that may impact access to telehealth for medication abortion.
In September 2016, a distraught mother sent infant formula maker Mead Johnson a message: “REMOVE ME FROM YOUR LIST!!!! DO NOT EMAIL OR MAIL ME ANY MORE! “It is because of your animal based pre-term artificial baby food crap that you peddle to hospital NICU’s that my son is dead from NEC.” The mother was…
Understanding how site augmentation services could be leveraged to overcome challenges is not the responsibility of one entity. The most creative and effective solutions arise from collaboration among all stakeholders — sponsors, CROs, service providers, and research sites. The post Bridging Clinical Research Gaps: How Site Augmentation Enhances Trial Success appeared first on MedCity News.
In this JAMA Health Forum post, KFF’s Larry Levitt outlines four reasons why high drug prices are in the spotlight more than hospital prices, even though hospitals accounted for 40% of the growth in national health spending from 2022 to 2024, and explores the potential for policy action to restrain them.
Healthcare leaders might be too confident about their AI readiness, according to new research. It showed that 70% of leaders feel at least somewhat confident in their organization’s AI governance frameworks, but only 15% report having scalable infrastructure in place. The post There’s a Gap Between Healthcare Leaders’ AI Confidence and Their Ability to Scale…
AstraZeneca is getting rights to a Sino Biopharmaceutical drug that offers a dual mechanism to treat chronic obstructive pulmonary disease, or COPD. It’s the same approach as an FDA-approved drug that Merck acquired last year in a multi-billion dollar deal. The post AstraZeneca Turns to China for Molecule That Might Top New Merck COPD Drug…